Related Experiment Video
Updated: May 24, 2026
07:01
Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
Published on: August 19, 2025
Hepcidin: A useful marker in chronic obstructive pulmonary disease
Serap Duru1, Esra Bilgin, Sadık Ardiç
1Diskapi Yildirim Beyazit Education and Research Hospital, Department of Chest Diseases, Ankara, Turkey.
Annals of Thoracic Medicine
|February 21, 2012
Summary
Serum hepcidin levels are lower in severe chronic obstructive pulmonary disease (COPD). This suggests hepcidin may help prevent hypoxemia and could be a useful biomarker for COPD patients.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Internal Medicine
Background:
- Chronic obstructive pulmonary disease (COPD) is a major global health concern.
- Hepcidin is a key regulator of iron metabolism and has potential roles in inflammatory conditions.
Purpose of the Study:
- To evaluate serum hepcidin levels in patients with varying severity of COPD.
- To explore the relationship between hepcidin levels and clinical parameters in COPD.
Main Methods:
- Serum hepcidin levels were measured in 74 male COPD patients (mild, moderate, severe) and 35 healthy controls.
- Hepcidin levels were compared across groups and correlated with age, BMI, smoking history, blood parameters, lung function, and arterial blood gases.
Main Results:
- No significant difference in hepcidin levels between healthy controls and mild COPD patients.
- Significantly lower hepcidin levels were observed in moderate and severe COPD patients compared to controls.
- In severe COPD, hepcidin levels positively correlated with serum iron, hematocrit, ferritin, and arterial oxygen saturation.
Conclusions:
- Decreased serum hepcidin in severe COPD may play a role in preventing hypoxemia.
- Serum hepcidin may serve as a potential biomarker for COPD.
- Further large-scale prospective studies are warranted to confirm these findings.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...